Cargando…

Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial

INTRODUCTION: Community engagement in research is widely accepted as best practice, despite gaps in existing frameworks to evaluate its process, context, and impact on research. The Screening in High Schools to Identify, Evaluate, and Lower Depression (SHIELD) study evaluated the use of a school-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoke, Alicia M., Rosen, Perri, Pileggi, Francesca, Molinari, Alissa, Sekhar, Deepa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044104/
https://www.ncbi.nlm.nih.gov/pubmed/36978148
http://dx.doi.org/10.1186/s40900-023-00425-6
_version_ 1784913292394758144
author Hoke, Alicia M.
Rosen, Perri
Pileggi, Francesca
Molinari, Alissa
Sekhar, Deepa L.
author_facet Hoke, Alicia M.
Rosen, Perri
Pileggi, Francesca
Molinari, Alissa
Sekhar, Deepa L.
author_sort Hoke, Alicia M.
collection PubMed
description INTRODUCTION: Community engagement in research is widely accepted as best practice, despite gaps in existing frameworks to evaluate its process, context, and impact on research. The Screening in High Schools to Identify, Evaluate, and Lower Depression (SHIELD) study evaluated the use of a school-based major depressive disorder screening tool in the identification of symptoms and treatment initiation among adolescents, and was developed, implemented, and disseminated in partnership with a Stakeholder Advisory Board (SAB). We summarize outcomes of the evaluation strategy applied through our partnership with the SAB and explore gaps in the available engagement evaluation tools for mixed stakeholder populations including youth. METHODS: SHIELD study SAB members (n = 13; adolescents, parents, mental health and primary care providers, and professionals from education and mental health organizations) advised on study design, implementation, and dissemination over a three-year period. Both SAB members and study team members (i.e., clinician researchers, project managers) were invited to quantitatively and qualitatively evaluate stakeholder engagement after each project year. At the conclusion of the study, SAB members and study team members were asked to evaluate the application of engagement principles in overall stakeholder engagement across the study period, using portions of the Research Engagement Survey Tool (REST). RESULTS: SAB members and study team members responded similarly when evaluating engagement process (i.e., valued on team, voice represented); means ranged from 3.9 to 4.8 out of 5 points across all three project years. Reported engagement within study-specific engagement activities (i.e., meetings, study newsletter) varied from year to year, with some discrepancy between SAB member and study team evaluations. Using REST, SAB members reported the alignment of their experience with key engagement principles the same or higher than study team members. Qualitative feedback at the conclusion of the study generally matched quantitative measures; adolescent SAB members, however, reported disengagement from stakeholder activities that was not accurately or effectively captured in evaluation strategies employed across the study period. CONCLUSIONS: Challenges exist in effectively engaging stakeholders and evaluating their engagement, particularly among heterogenous groups that include youth. Evaluation gaps should be addressed through the development of validated instruments that quantify the process, context, and impact of stakeholder engagement on study outcomes. Consideration should be given to collecting parallel feedback from stakeholders and study team members to fully understand the application and execution of engagement strategy.
format Online
Article
Text
id pubmed-10044104
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100441042023-03-28 Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial Hoke, Alicia M. Rosen, Perri Pileggi, Francesca Molinari, Alissa Sekhar, Deepa L. Res Involv Engagem Research INTRODUCTION: Community engagement in research is widely accepted as best practice, despite gaps in existing frameworks to evaluate its process, context, and impact on research. The Screening in High Schools to Identify, Evaluate, and Lower Depression (SHIELD) study evaluated the use of a school-based major depressive disorder screening tool in the identification of symptoms and treatment initiation among adolescents, and was developed, implemented, and disseminated in partnership with a Stakeholder Advisory Board (SAB). We summarize outcomes of the evaluation strategy applied through our partnership with the SAB and explore gaps in the available engagement evaluation tools for mixed stakeholder populations including youth. METHODS: SHIELD study SAB members (n = 13; adolescents, parents, mental health and primary care providers, and professionals from education and mental health organizations) advised on study design, implementation, and dissemination over a three-year period. Both SAB members and study team members (i.e., clinician researchers, project managers) were invited to quantitatively and qualitatively evaluate stakeholder engagement after each project year. At the conclusion of the study, SAB members and study team members were asked to evaluate the application of engagement principles in overall stakeholder engagement across the study period, using portions of the Research Engagement Survey Tool (REST). RESULTS: SAB members and study team members responded similarly when evaluating engagement process (i.e., valued on team, voice represented); means ranged from 3.9 to 4.8 out of 5 points across all three project years. Reported engagement within study-specific engagement activities (i.e., meetings, study newsletter) varied from year to year, with some discrepancy between SAB member and study team evaluations. Using REST, SAB members reported the alignment of their experience with key engagement principles the same or higher than study team members. Qualitative feedback at the conclusion of the study generally matched quantitative measures; adolescent SAB members, however, reported disengagement from stakeholder activities that was not accurately or effectively captured in evaluation strategies employed across the study period. CONCLUSIONS: Challenges exist in effectively engaging stakeholders and evaluating their engagement, particularly among heterogenous groups that include youth. Evaluation gaps should be addressed through the development of validated instruments that quantify the process, context, and impact of stakeholder engagement on study outcomes. Consideration should be given to collecting parallel feedback from stakeholders and study team members to fully understand the application and execution of engagement strategy. BioMed Central 2023-03-28 /pmc/articles/PMC10044104/ /pubmed/36978148 http://dx.doi.org/10.1186/s40900-023-00425-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hoke, Alicia M.
Rosen, Perri
Pileggi, Francesca
Molinari, Alissa
Sekhar, Deepa L.
Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial
title Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial
title_full Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial
title_fullStr Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial
title_full_unstemmed Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial
title_short Evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial
title_sort evaluation of a stakeholder advisory board for an adolescent mental health randomized clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044104/
https://www.ncbi.nlm.nih.gov/pubmed/36978148
http://dx.doi.org/10.1186/s40900-023-00425-6
work_keys_str_mv AT hokealiciam evaluationofastakeholderadvisoryboardforanadolescentmentalhealthrandomizedclinicaltrial
AT rosenperri evaluationofastakeholderadvisoryboardforanadolescentmentalhealthrandomizedclinicaltrial
AT pileggifrancesca evaluationofastakeholderadvisoryboardforanadolescentmentalhealthrandomizedclinicaltrial
AT molinarialissa evaluationofastakeholderadvisoryboardforanadolescentmentalhealthrandomizedclinicaltrial
AT sekhardeepal evaluationofastakeholderadvisoryboardforanadolescentmentalhealthrandomizedclinicaltrial